Those canine results should be the start of an immediate new market and cash flow. How many millions of owners of dogs with arthritis are there in the world? They would pounce on a product that alleviates and reverses the disease and suffering of their pets. I know this from sad experience. Cartrofen was helpful but our drug is in a different league. I suspect that the pet market worldwide would be huge.
Ann: 2023 Annual Report and Appendix 4E, page-8
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
0.005(1.92%) |
Mkt cap ! $92.69M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 25.5¢ | $222.9K | 844.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 44553 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 7500 | 1 |
View Market Depth
| Last trade - 13.42pm 28/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |